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Abstract
Objective: Intrauterine devices (IUDs) are used for contra-
ception worldwide; however, the management of pregnancies
with an IUD poses a clinical challenge. The purpose of this
study was to determine the outcome of pregnancy in patients
with an IUD.
Study design: A retrospective cohort study (December
1997–June 2007) was conducted. The cohort consisted of
12,297 pregnancies, of which 196 had an IUD. Only single-
ton pregnancies were included. Logistic regression analysis
was used to adjust for potential confounders between the
groups.
Results: 1) Pregnancies with an IUD were associated with
a higher rate of late miscarriage, preterm delivery, vaginal
bleeding, clinical chorioamnionitis, and placental abruption
than those without an IUD; 2) among patients with available
histologic examination of the placenta, the rate of histologic
chorioamnionitis and/or funisitis was higher in patients with
an IUD than in those without an IUD (54.2% vs. 14.7%;
P-0.001). Similarly, among patients who underwent an
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amniocentesis, the prevalence of microbial invasion of the
amniotic cavity (MIAC) was also higher in pregnant women
with an IUD than in those without an IUD (45.9% vs. 8.8%;
P-0.001); and 3) intra-amniotic infection caused by Can-
dida species was more frequently present in pregnancies with
an IUD than in those without an IUD (31.1% vs. 6.3%;
P-0.001).
Conclusion: Pregnant women with an IUD are at a very high
risk for adverse pregnancy outcomes. This finding can be
attributed, at least in part, to the high prevalence of intra-
amniotic infection and placental inflammatory lesions
observed in pregnancies with an IUD.
Keywords: Chorioamnionitis; intrauterine device; microbial
invasion of the amniotic cavity; pregnancy; prematurity; pre-
term delivery; preterm labor; preterm prelabor rupture of the
membranes.
Introduction
Intrauterine devices (IUDs) are used for contraception world-
wide. Despite the presence of an IUD, the failure rate of this
contraceptive method ranges from 0.3 to 2.3% w12, 39, 40,
51x. Compelling evidence has demonstrated that pregnancies
with an IUD are associated with an increased risk of spon-
taneous abortion and preterm delivery due to infection w2,
52x, and the risk of maternal septic complications also
increases in such cases w18x. It has been reported that the
miscarriage rate is reduced if the IUD is removed in early
pregnancy w18, 48, 52x, and it is recommended that the IUD
should be removed during the first trimester of pregnancy
w17x. However, if the IUD remains in the uterine cavity dur-
ing pregnancy, the management of such pregnancies poses a
clinical challenge. There is a paucity of data about the prev-
alence and clinical significance of intra-amniotic infection
and placental inflammation associated with pregnancies with
a retained IUD. The purpose of this study was to determine
the outcomes of pregnancy in patients with an IUD in a large
unselected population.
Patients and methods
Study design and population
A retrospective cohort study was conducted including women who
delivered at the Sótero del Rio Hospital (Santiago, Chile) from
December 1997 to June 2007. This cohort consisted of 12,297 preg-
nancies, of which 196 had a Copper T 380A IUD in situ during
pregnancy. Only singleton pregnancies and parous women were
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included. Patients post-IUD removal during early pregnancy
(ns12) were excluded. All patients provided written informed con-
sent at the time of enrolment. The Institutional Review Boards of
both the Sótero del Rio Hospital and the Eunice Kennedy Shriver
National Institute of Child Health and Human Development, Nation-
al Institutes of Health (NICHD/NIH/DHHS) approved the collection
of biologic materials and data from these patients for research
purposes.
Clinical definitions
Preterm birth was defined as delivery occurring before 37 completed
weeks of gestation. Spontaneous preterm labor (PTL) was defined
by the presence of regular uterine contractions occurring at a fre-
quency of at least two every 10 min associated with cervical chang-
es before 37 completed weeks of gestation that required
hospitalization w25x. The diagnosis of preterm prelabor rupture of
the membranes (preterm PROM) was confirmed by pooling of
amniotic fluid in the vagina in association with positive nitrazine
and ferning tests or by a positive amniocentesis-dye test before 37
completed weeks of gestation. Indicated preterm birth was defined
as delivery of a preterm neonate because of medical or obstetrical
complications that threatened maternal or fetal condition. Preeclamp-
sia was defined as the presence of hypertension (systolic blood pres-
sure G140 mm Hg and/or diastolic blood pressure G90 mm Hg on
at least two occasions, 4 h–1 week apart), occurring after 20 weeks
of gestation in a woman with previously normal blood pressure, and
proteinuria (G300 mg in a 24-h urine collection or one dipstick
measurement G1q) w1x. A small for gestational age (SGA) neonate
was defined as birth weight below the 10th percentile for gestational
age w23x. Clinical chorioamnionitis was diagnosed in the presence
of fever (G37.88C) and two or more of the following criteria: uter-
ine tenderness, malodorous vaginal discharge, maternal tachycardia
(G100 beats/min), maternal leukocytosis (G15,000 cells/mm3), and
fetal tachycardia (G160 beats/min) w19x. Placental abruption was
identified based on a clinical diagnosis which included the follow-
ing criteria: 1) painful vaginal bleeding; 2) uterine tenderness or
hypertonicity; and 3) retroplacental hematoma on the placental sur-
face or on the basis of prenatal sonographic diagnosis w59x. Spon-
taneous abortion was defined as spontaneous pregnancy termination
prior to 20 weeks of gestation.
Composite neonatal morbidity was defined as the presence of any
following conditions: neonatal sepsis or suspected sepsis, respira-
tory distress syndrome, patent ductus arteriosus, bronchopulmonary
dysplasia, intraventricular hemorrhage, or necrotizing enterocolitis.
Neonatal sepsis was diagnosed in the presence of a positive blood
culture. Suspected neonatal sepsis was diagnosed in the absence of
a positive blood culture when two or more of the following criteria
were present: 1) white blood cell (WBC) count of -5000 cells/
mm3; 2) polymorphonuclear leukocyte count of -1800 cells/mm3;
and 3) ratio of immature neutrophils to total neutrophils )0.2 w21x.
The diagnosis of respiratory distress syndrome required the presence
of respiratory grunting and retracting, increased need for oxygen,
and diagnostic radiographic and laboratory findings in the absence
of evidence for other causes of respiratory disease w21x. Patent duc-
tus arteriosus was diagnosed by the presence of clinical signs and
symptoms (heart murmur, increased pulse pressure, decreased mean
arterial blood pressure, and bounding peripheral pulses) and con-
firmed by an echocardiogram demonstrating blood flow (left to right
or bi-directional) through the patent ductus arteriosus w58x. Bron-
chopulmonary dysplasia was diagnosed if the neonate required oxy-
gen and ventilatory therapy for )28 days during the first 2 months
of life, had typical radiographic changes and/or had dysplasia of the
bronchopulmonary tree at autopsy w29x. Intraventricular hemorrhage
was diagnosed by ultrasonographic examination of the neonatal
head. Necrotizing enterocolitis was diagnosed in the presence of
abdominal distention and feeding intolerance for at least 24 h (vom-
iting or increased gastric residual) with clear radiologic evidence of
intramural air, perforation, meconium plug syndrome, or definite
surgical or autopsy findings of necrotizing enterocolitis w21x.
Amniotic fluid sample collection
Amniocentesis was performed at the discretion of the treating phy-
sician. Amniotic fluid samples were obtained by transabdominal
amniocentesis or at the time of cesarean delivery. All specimens
were cultured for the presence of microorganisms including aerobic
and anaerobic bacteria as well as genital Mycoplasmas. WBC count,
glucose concentration, and Gram stain were also performed shortly
after collection as previously described w41–43x. Intra-amniotic
infection was defined as a positive amniotic fluid culture for micro-
organisms. Intra-amniotic inflammation was diagnosed by an amni-
otic fluid WBC count )50 cells/mm3 w43x.
Histopathologic examination of the placenta
Pathologic examination of the placenta was performed systemati-
cally based on the diagnostic criteria previously described w38x. The
maternal inflammatory response (histologic chorioamnionitis) was
described in detail as follows: 1) acute subchorionitis/chorionitis
(stage 1 early); 2) acute chorioamnionitis (stage 2 intermediate);
3) necrotizing chorioamnionitis (stage 3 late); 4) subacute chorioam-
nionitis (stage 3 late); and 5) subchorionic microabscess (severe).
The fetal inflammatory response (funisitis) was also classified as
follows by inflammation in the umbilical cord: 1) umbilical phle-
bitis/chorionic vasculitis (stage 1 early); 2) umbilical arteritis (stage
2 intermediate); 3) necrotizing funisitis (stage 3 late); and 4) intense
chorionic vasculitis with recent non-occlusive chorionic vessel
thrombi (severe).
Statistical analysis
The normality of the data was tested using Shapiro-Wilk and Kol-
mogorov-Smirnov tests. Since the data were normally distributed,
mean and standard deviation were reported for continuous variables,
and the number and percentage were presented for categorical
variables. Differences in the continuous variables between the two
groups were estimated using Student t-test. Comparisons of propor-
tions were performed by x2 or Fisher’s exact tests. Associations
between the presence of IUD in pregnancy and the obstetrical out-
comes were analyzed by means of logistic regression models with
adjustment for confounding factors: maternal age, parity, history of
preterm birth, gestational age at delivery, underlying medical con-
dition, smoking status, and pre-pregnancy body mass index (BMI).
A P-0.05 was considered statistically significant. The statistical
analyses were performed using SPSS version 12.0 (SPSS Inc,
Chicago, IL, USA).
Results
Demographic characteristics and obstetrical
outcomes of the study population
Table 1 presents the demographic characteristics and obstet-
rical outcomes of the study population. Pregnancies with an
IUD had a significantly lower mean gestational age at deliv-
ery than those without an IUD (P-0.001), and were asso-
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Table 1 Demographic characteristics and obstetrical outcomes of the study population.
Variable No IUD Pregnancy with an IUD Crude Adjusted
(ns12,101) (ns196) OR (95% CI) OR (95% CI)
Characteristics
Age (years) 29.6"6.5 29.5"7.3 1.0 (0.9–1.0)
Parity 1.8"1.2 1.9"1.0 1.0 (0.9–1.1)
Gestational age at delivery (weeks) 37.5"5.1 28.5"8.6 0.8 (0.8–0.9)
History of preterm birth 1683 (13.9) 24 (12.2) 0.9 (0.6–1.3)
Underlying medical condition 1273 (10.5) 16 (8.2) 0.8 (0.5–1.3)
Smoking 1609 (13.4) 17 (8.8) 0.6 (0.4–1.1)
Pre-pregnancy BMI (kg/m2) 26.0"5.1 26.9"5.0 1.0 (0.9–1.0)
Obstetrical outcomes
Preterm birth 2503 (20.7) 110 (56.1) 4.9 (3.7–6.5) 5.8 (4.3–8.0)*
Spontaneous preterm labor 946 (7.8) 34 (17.3) 2.5 (1.7–3.6) 2.5 (1.7–3.8)*
Preterm PROM 714 (5.9) 68 (34.7) 8.5 (6.3–11.5) 9.4 (6.8–13.0)*
Indicated preterm birth 843 (7.0) 8 (4.1) 0.6 (0.3–1.2) 0.7 (0.3–1.4)*
Late spontaneous abortion ()12 weeks) 146 (1.2) 31 (15.8) 15.4 (10.1–23.3) 16.8 (10.6–26.7)*
Fetal death 188 (1.6) 9 (4.6) 3.0 (1.5–6.0) 1.5 (0.7–3.2)**
Preeclampsia 557 (4.6) 4 (2.0) 0.4 (0.2–1.2) 0.6 (0.2–1.6)**
SGA 1141 (9.4) 10 (5.1) 0.5 (0.3–1.0) 0.7 (0.4–1.4)**
Vaginal bleeding 657 (5.4) 37 (18.9) 4.1 (2.8–5.8) 3.1 (2.1–4.7)**
Clinical chorioamnionitis 209 (1.7) 16 (8.2) 5.1 (3.0–8.6) 4.1 (2.3–7.2)**
Placental abruption 249 (2.1) 16 (8.2) 4.2 (2.5–7.2) 3.4 (2.0–5.9)**
Placenta previa 186 (1.5) 4 (2.0) 1.3 (0.5–3.6) 0.7 (0.2–2.9)**
Cesarean delivery 3765 (31.1) 61 (31.1) 1.0 (0.7–1.4) 1.4 (0.9–2.1)**
Fetal congenital malformation 828 (6.8) 15 (7.7) 1.1 (0.6–1.9) 1.4 (0.8–2.4)**
Data are expressed as number (percentage) or mean"SD.
ORsodds ratio, CIsconfidence interval, IUDsintrauterine device, BMIsbody mass index, PROMsprelabor rupture of the membranes,
SGAssmall for gestational age.
*Adjusted for age, parity, history of preterm birth, underlying medical condition, smoking, and pre-pregnancy BMI.
**Adjusted for age, parity, gestational age at delivery, underlying medical condition, smoking, and pre-pregnancy BMI.
ciated with a higher rate of spontaneous PTL, preterm
PROM, and late spontaneous abortion ()12 weeks of ges-
tation). These results remained significant after adjustment
for maternal age, parity, history of preterm birth, underlying
medical condition, smoking status, and pre-pregnancy BMI.
Moreover, pregnancies with an IUD were associated with a
higher rate of vaginal bleeding, clinical chorioamnionitis,
and placental abruption than those without an IUD. These
results remained significant after adjustment for maternal
age, parity, gestational age at delivery, underlying medical
condition, smoking status, and pre-pregnancy BMI.
Amniotic fluid analysis
Amniocenteses were performed on 2081 patients from the
study population. The indications and laboratory results of
amniotic fluid analysis are shown in Table 2. Patients with
an IUD more frequently underwent amniocentesis for the
detection of microbial invasion of the amniotic cavity
(MIAC) than those without an IUD (94.9% vs. 66.8%;
P-0.001). The mean gestational age at amniocentesis was
earlier in patients with an IUD than in those without an IUD
(26.1"6 weeks vs. 32.6"6 weeks; P-0.001). Overall, the
prevalence of a positive amniotic fluid culture was higher in
patients with an IUD than in those without an IUD (45.9%
vs. 8.8%; P-0.001). After adjustment for gestational age at
amniocentesis, logistic regression analysis showed that the
presence of IUD in pregnancy was an independent explan-
atory variable for the occurrence of MIAC; the adjusted odds
ratio (OR) was 4.9 w95% confidence interval (CI), 3.1–7.8x.
Table 3 displays the amniotic fluid analysis of patients with
spontaneous PTL with intact membranes and that of those
with preterm PROM according to the presence or absence of
IUD in pregnancy. The prevalence of a positive amniotic
fluid culture was higher in patients with an IUD than in those
without an IUD among both cases of spontaneous PTL with
intact membranes (38.5% vs. 5.2%; P-0.001) and preterm
PROM (57.1% vs. 27.0%; P-0.001). Table 4 displays the
microorganisms isolated from the amniotic fluid. Ureaplas-
ma urealyticum was the most frequent microorganism iso-
lated from the amniotic cavity of patients both with (48.9%)
and without (48.9%) an IUD. Candida species was the sec-
ond common microorganism isolated from the amniotic fluid
of patients with an IUD, and significantly more frequent in
patients with an IUD than in those without an IUD (31.1%
vs. 6.3%; P-0.001).
Placental histology
Placental histopathologic examinations were available for
43.4% (5340/12,297) of the study population (pregnancies
with an IUD, 54.6% w107/196x; those without an IUD, 43.2%
w5233/12,101x). The diagnosis of chorioamnionitis was strat-
ified based on the presence of either a maternal and/or fetal
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Table 2 Indications and laboratory results of amniotic fluid analysis according to the presence or absence of intrauterine device in
pregnancy.
Variable No IUD Pregnancy with an IUD P-value
(ns1983) (ns98)
Indication
Detection of MIAC 1324 (66.8) 93 (94.9) -0.001
Evaluation of fetal lung maturity 194 (9.8) 3 (3.1) 0.021
Karyotyping 53 (2.7) 0 (0) NS
Treatment of polyhydramnios 4 (0.2) 0 (0) NS
Rh isoimmunization 37 (1.9) 0 (0) NS
Obtained at cesarean delivery 371 (18.7) 2 (2.0) -0.001
Laboratory result
WBC count )50 cells/mm3 235 (11.9) 44 (44.9) -0.001
Glucose concentration -14 mg/dL 709 (35.8) 59 (60.2) -0.001
Positive Gram stain 63 (3.2) 11 (11.2) -0.001
Positive culture for microorganism 174 (8.8) 45 (45.9) -0.001
Intra-amniotic infection/inflammation 309 (15.6) 59 (60.2) -0.001
Data are expressed as number (percentage).
IUDsintrauterine device, MIACsmicrobial invasion of the amniotic cavity, WBCswhite blood cell, NSsnot significant.
Table 3 Amniotic fluid analysis among cases with spontaneous PTL and preterm PROM according to the presence or absence of intrauterine
device in pregnancy.
Laboratory result No IUD Pregnancy with an IUD P-value
Spontaneous PTL with intact membranes ns762 ns26
WBC )50 cells/mm3 47 (6.2) 7 (26.9) -0.001
Glucose concentration -14 mg/dL 168 (22.0) 15 (57.7) -0.001
Positive Gram stain 23 (3.0) 3 (11.5) NS
Positive culture for microorganism 40 (5.2) 10 (38.5) -0.001
Intra-amniotic infection/inflammation 68 (8.9) 11 (42.3) -0.001
Preterm PROM ns348 ns49
WBC )50 cells/mm3 124 (35.6) 32 (65.3) -0.001
Glucose concentration -14 mg/dL 131 (37.6) 33 (67.3) -0.001
Positive Gram stain 28 (8.0) 5 (10.2) NS
Positive culture for microorganism 94 (27.0) 28 (57.1) -0.001
Intra-amniotic infection/inflammation 156 (44.8) 38 (77.6) -0.001
Data are expressed as number (percentage).
PTLspreterm labor, PROMsprelabor rupture of the membranes, IUDsintrauterine device, WBCswhite blood cell, NSsnot significant.
inflammatory response. The rate of histologic chorioamnion-
itis and/or funisitis was higher in patients with an IUD than
in those without an IUD (Table 5). Histologic chorioamnion-
itis was more common in patients with an IUD compared to
those without an IUD (Table 5); and the rates of acute cho-
rioamnionitis, necrotizing chorioamnionitis, and subacute
chorioamnionitis were higher in patients with an IUD than
in those without an IUD (Table 5). Similarly, funisitis was
more common in patients with an IUD compared to those
without an IUD (Table 5); and the rates of umbilical phle-
bitis/chorionic vasculitis, umbilical arteritis, and necrotizing
funisitis were higher in patients with an IUD than in those
without an IUD (Table 5). After adjustment for gestational
age at delivery, logistic regression analysis showed that the
presence of an IUD in pregnancy was an independent explan-
atory variable for the occurrence of histologic chorioamnion-
itis and/or funisitis; the adjusted OR was 3.4 (95% CI,
2.2–5.3). In cases of placental abruption, placental histologic
examinations were available for 115 patients; the rate of his-
tologic chorioamnionitis and/or funisitis was higher in cases
of placental abruption with an IUD than in those without an
IUD (76.9% w10/13x vs. 14.7% w15/102x, P-0.001).
Neonatal outcomes
Neonates born to mothers with an IUD had a lower mean
birth weight (P-0.001) and a higher rate of Apgar score of
-7 at 5 min (P-0.001) than those of mothers without an
IUD. In addition, a significantly higher proportion of neo-
nates born to mothers with an IUD had neonatal sepsis or
suspected sepsis, respiratory distress syndrome, patent ductus
arteriosus, bronchopulmonary dysplasia, intraventricular
hemorrhage, necrotizing enterocolitis, and neonatal death
than those born to mothers without an IUD (Table 6). How-
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Table 4 Culture isolates from amniotic fluid according to the presence or absence of intrauterine device in pregnancy.
Species No IUD Pregnancy with an IUD P-value
(ns174) (ns45)
Ureaplasma urealyticum 85 (48.9) 22 (48.9) NS
Candida species 11 (6.3) 14 (31.1) -0.001
Staphylococcus coagulase (–) 14 (8.0) 6 (13.3) NS
Mycoplasma hominis 19 (10.9) 5 (11.1) NS
Staphylococcus coagulase (q) 4 (2.3) 2 (4.4) NS
Streptococcus viridans 4 (2.3) 1 (2.2) NS
Streptococcus pneumoniae 3 (1.7) 1 (2.2) NS
Enterococcus species 10 (5.7) 1 (2.2) NS
Peptostreptococcus 3 (1.7) 1 (2.2) NS
Others 55 (31.6) 0 (0) -0.001
Data are expressed as number (percentage).
IUDsintrauterine device, NSsnot significant.
Table 5 Histologic analysis of the placenta according to the presence or absence of intrauterine device in pregnancy.
Histologic finding No IUD Pregnancy with an IUD P-value
(ns5233) (ns107)
Histologic chorioamnionitis, maternal response
Any 672 (12.8) 56 (52.3) -0.001
Stage 1 early: acute subchorionitis/chorionitis 446 (8.5) 5 (4.7) NS
Stage 2 intermediate: acute chorioamnionitis 157 (3.0) 14 (13.1) -0.001
Stage 3 late: necrotizing chorioamnionitis 48 (0.9) 22 (20.6) -0.001
Stage 3 late: subacute chorioamnionitis 16 (0.3) 14 (13.1) -0.001
Severe: subchorionic microabscess 5 (0.1) 1 (0.9) NS
Funisitis, fetal response
Any 440 (8.4) 47 (43.9) -0.001
Stage 1 early: umbilical phlebitis/chorionic vasculitis 319 (6.1) 18 (16.8) -0.001
Stage 2 intermediate: umbilical arteritis 96 (1.8) 20 (18.7) -0.001
Stage 3 late: necrotizing funisitis 22 (0.4) 8 (7.5) -0.001
Severe: intense chorionic vasculitis with recent 3 (0.1) 1 (0.9) NS
non-occlusive chorionic vessel thrombi
Histologic chorioamnionitis and/or funisitis 770 (14.7) 58 (54.2) -0.001
Data are expressed as number (percentage).
IUDsintrauterine device, NSsnot significant.
ever, the presence of an IUD in pregnancy was not an inde-
pendent explanatory variable for composite neonatal
morbidity after adjustment for gestational age at delivery; the
adjusted OR was 0.7 (95% CI, 0.5–1.2). Of interest, among
cases with term delivery and no evidence of histologic
chorioamnionitis and/or funisitis, the prevalence of neonatal
sepsis or suspected sepsis was higher in neonates born to
mothers with an IUD than in those without IUD (7.7%
w2/26x vs. 1.2% w42/3544x, Ps0.04).
Discussion
Principal findings of this study
Pregnancies with an IUD: 1) had a higher rate of MIAC and
histologic chorioamnionitis; 2) had a higher rate of intra-
amniotic infection caused by Candida species; 3) were asso-
ciated with a higher rate of late miscarriage, preterm delivery,
vaginal bleeding, clinical chorioamnionitis, and placental
abruption; and 4) had poorer neonatal outcomes in compar-
ison to pregnancies without an IUD.
Pregnancy with an IUD, intra-amniotic infection, and
microbial biofilms
We report for the first time the placental histologic evaluation
of pregnancies with an IUD in a cohort study using stan-
dardized criteria for placental findings consistent with intra-
amniotic infection. Among patients with available placental
histologic evaluation, the rate of histologic chorioamnionitis
was higher in patients with an IUD than in those without an
IUD. Moreover, among the lesions for both maternal and
fetal responses of chorioamnionitis, severe inflammatory
lesions, such as necrotizing chorioamnionitis and umbilical
arteritis were observed more frequently in patients with an
IUD than in those without an IUD. Similarly, amniotic fluid
analyses among both cases of spontaneous PTL with intact
membranes and preterm PROM showed a higher prevalence
of intra-amniotic infection/inflammation in patients with an
50 Kim et al., Prognosis of pregnancies with an IUD
Article in press - uncorrected proof
Table 6 Neonatal outcomes according to the presence or absence of intrauterine device in pregnancy.
Neonatal outcome No IUD Pregnancy with an IUD P-value
(ns11,632) (ns151)
Birth weight (g) 3208"1012 2211"1133 -0.001
Apgar score -7 at 5 min 248 (2.1) 20 (13.2) -0.001
NICU admission 1524 (13.1) 64 (42.4) -0.001
Neonatal sepsis or suspected sepsis 686 (5.9) 36 (23.8) -0.001
Respiratory distress syndrome 256 (2.2) 18 (11.9) -0.001
Patent ductus arteriosus 188 (1.6) 8 (5.3) 0.002
Bronchopulmonary dysplasia 91 (0.8) 11 (7.3) -0.001
Intraventricular hemorrhage 97 (0.8) 10 (6.6) -0.001
Necrotizing enterocolitis 49 (0.4) 5 (3.3) -0.001
Composite neonatal morbidity* 923 (7.9) 55 (36.4) -0.001
Neonatal death 174 (1.5) 16 (10.6) -0.001
Data are expressed as number (percentage) or mean"SD.
IUDsintrauterine device, NICUsneonatal intensive care unit.
*Defined as the presence of any of the following conditions: neonatal sepsis or suspected sepsis, respiratory distress syndrome, patent ductus
arteriosus, bronchopulmonary dysplasia, intraventricular hemorrhage, or necrotizing enterocolitis.
IUD compared to those without an IUD. Previous studies
have demonstrated the formation of biofilms on the IUD sur-
face w6, 9, 35, 37x. Biofilms are defined as structured com-
munities of microorganisms characterized by cells that are
attached to a living or inert surface w15x. Bacterial biofilms
have been implicated in several infectious diseases, such as
periodontitis, otitis media, endocarditis, prostatitis, biliary
tract infections, and many others associated with a medical
device w10x. It has been previously reported that bacteria can
develop a biofilm in the amniotic cavity and that such a
biofilm has been found in a case with amniotic fluid
‘‘sludge’’ w44x. Indeed, the presence of amniotic fluid
‘‘sludge’’ is an independent risk factor for MIAC, histologic
chorioamnionits, and spontaneous preterm delivery in
patients with PTL and intact membranes as well as asymp-
tomatic patients with a short cervix w16, 31x. Since IUDs are
in the uterine cavity, not inside the amniotic cavity, future
studies are warranted to determine the prevalence of amniotic
fluid ‘‘sludge’’ and the presence of microbial biofilms in the
amniotic fluid of pregnant women with an IUD.
Pregnancy with an IUD and Candida infection
Ureaplasma urealyticum and Mycoplasma hominis are the
most common microorganism in intra-amniotic infection
w45x, which is consistent with the findings reported herein.
In addition, this study reported a higher rate of intra-amniotic
infection caused by Candida species in pregnancies with an
IUD than in those without an IUD. These findings are in
agreement with previous reports demonstrating an associa-
tion between intra-amniotic Candida infection and pregnan-
cies with an IUD w8, 14, 28, 33, 46, 47, 50, 57x. Candida
species are common saprophytes in the genital tract and are
present in up to 20–25% of pregnant women w55x. Despite
the frequent prevalence of vaginal Candida infection during
pregnancy, intra-amnioitc infection caused by Candida spe-
cies is rare. Previous studies suggested two mechanisms by
which Candida species could gain access to the amniotic
cavity in pregnancies with an IUD: 1) endometrial yeast con-
tamination may be present at the time of IUD insertion w47x;
and 2) the strings of an IUD may serve as a route for ascend-
ing infection w13x. Chassot et al. w9x have demonstrated the
in vitro adhesive capacity to IUDs of Candida albicans iso-
lated from vaginal exudates of patients with vaginal candi-
diasis, and its formation of a biofilm which makes a
progressive source of infection. Because of the higher prev-
alence of intra-amniotic Candida infection in pregnancies
with an IUD, an accurate diagnosis and treatment should be
considered.
Retained IUD and adverse pregnancy outcome
Several studies have reported a higher rate of miscarriage in
women who conceive an intrauterine pregnancy despite the
presence of an IUD w18, 48, 52x. Moreover, the present study
showed a higher rate of fetal death. However, there was no
significant association between the rate of fetal death and the
presence of an IUD after adjustment for confounding factors,
such as maternal age, parity, gestational age at delivery,
underlying medical condition, smoking, and pre-pregnancy
BMI.
The results of this study support an association between
the presence of an IUD in pregnancy and preterm birth w7,
52x. Epidemiologic studies of preterm birth reveal that
40–45% of preterm births follow spontaneous PTL with
intact membranes, 25–30% follow preterm PROM, and
30–35% are delivery for maternal or fetal indications w20,
49x, which is consistent with findings of the present study.
However, in pregnancies with an IUD, preterm PROM was
the most common cause of preterm birth. The ultimate cause
of membrane rupture in many cases of preterm PROM is
unknown, but asymptomatic intrauterine infection is consid-
ered as a frequent precursor w20x. Of interest, pregnancies
with an IUD were independently associated with preterm
birth and preterm PROM even after adjustment for histologic
chorioamnionitis and/or funisitis (data not shown).
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Idiopathic vaginal bleeding during pregnancy has been
proposed as one of the clinical manifestations of intrauterine
infection w22x. Vaisbuch et al. w54x suggested that the total
hemoglobin concentration in amniotic fluid is increased in
intra-amniotic infection/inflammation. In the present study,
pregnancies with an IUD were associated with a higher rate
of vaginal bleeding. Thus, our findings are concordant with
previous studies reporting that MIAC is associated with vag-
inal bleeding that may lead to subsequent preterm PROM
and early preterm delivery w22, 54x. Moreover, patients with
an IUD had a higher rate of clinical chorioamnionitis than
patients without an IUD. This is consistent with the findings
that the rates of histologic chorioamnionitis and MIAC were
higher in patients with an IUD than in those without an IUD.
We have also demonstrated that pregnancies with an IUD
were associated with a higher prevalence of placental abrup-
tion than pregnant women without an IUD. Although the
primary etiology of placental abruption remains elusive, epi-
demiologic studies have identified an increased incidence of
placental abruption in patients with a history of placental
abruption, advanced maternal age, smoking, cocaine use,
poor nutrition or socioeconomic status, multiparity, hyper-
tensive disorders, chorioamnionitis, and preterm PROM w4,
5, 11, 27, 30, 36, 53, 56x. A previous study linked a chronic
inflammatory process of placenta to placental abruption w3x.
Indeed, an increased risk of placental abruption is associated
with acute and chronic inflammatory processes that activate
cytokines such as interleukin-1b and tumor necrosis factor-
a w3x. Nath et al. w34x have demonstrated that histologic
chorioamnionitis is associated with placental abruption.
Moreover, neutrophil infiltration of the fetal membranes has
been implicated in the association between preterm PROM
and placental abruption, suggesting that the enhanced pro-
tease activity and expression by inflammatory cytokines in
preterm PROM is involved in placental abruption w26, 34x.
In this study, the rate of histologic chorioamnionitis and/or
funisitis was higher in cases of placental abruption with an
IUD than in those without an IUD. Thus, our findings sup-
port the hypothesis that an inflammatory state may contribute
to the risk for placental abruption, preterm PROM, and spon-
taneous PTL with intact membranes.
A significantly higher proportion of neonates born to
mothers with an IUD was admitted to neonatal intensive care
unit (NICU) and had severe neonatal morbidity than that of
those without an IUD. As expected, the most important fac-
tor associated with adverse neonatal outcomes was gesta-
tional age at delivery. However, among cases with term
delivery and no evidence of histologic chorioamnionitis and/
or funisitis, the prevalence of neonatal sepsis or suspected
sepsis was higher in neonates born to mothers with an IUD
than that of those without IUD. The susceptibility of term
neonates born to mothers with an IUD to neonatal sepsis or
suspected sepsis can be attributed to other pathogenesis in
addition to gestational age at delivery and intrauterine
inflammation. In accordance with previous studies w24, 32x,
the risk of congenital malformation was not increased in neo-
nates born to mothers with an IUD compared to those with-
out an IUD.
Several studies have established a higher risk of compli-
cations, such as miscarriage and sepsis, in pregnancies with
a retained IUD than in those with early IUD removal w2, 18,
48, 52x. For this reason, the US Food and Drug Administra-
tion (FDA) recommends that IUDs whose tails are visible be
removed in early pregnancy w17x. In our population there was
no difference in obstetrical complications between pregnan-
cies with a retained IUD and those with early IUD removal
(data not shown). It is possible that the small sample size of
cases following IUD removal during early pregnancy
(ns12) may account for these results, and larger study is
needed to answer this research question.
In conclusion, this study provides evidence that pregnan-
cies with a retained IUD are at increased risk for adverse
pregnancy outcomes. This finding can be attributed, at least
in part, to the higher rate of intraamniotic infection and pla-
cental inflammatory lesions observed in pregnancies with an
IUD than in those without an IUD.
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